Changing Trends in Diabetic Foot Management

wound identification and reduces the subjectivity of clinical evaluation.By implementing this standardization, it is projected that healthcare professionals could get more accurate data, facilitate early diagnosis, and apply better treatment protocols.It is noted in other publications that rapid access to vascular assessment and intervention has been a game changer, as timely revascularization often determines whether an ulcer heals or progresses. 1,2e also know that wound-care science has become far more sophisticated.Traditional dressings are increasingly supplemented by advanced therapies such as bioengineered skin substitutes, negative-pressure wound therapy, and growth-factor-based treatments.Although not universally required, these modalities can accelerate healing in appropriately selected patients.Technological innovation and enhancement of surgical techniques have also been central to the changing trends in management of Charcot's foot in diabetes.In the current issue, Simon et al. 5 present a novel staged approach in managing infected, unstable Charcot hindfoot problems, using an ACI-TENS Nail.The technique, which involves cement coating of the nail inside the operating theater (OT), may evolve to be a useful method in fundrestrained environments like Asia and Africa, where this type of late problem is perhaps most commonly seen.Many of these cases present with comorbidities, which complicate the issue; Ya'Kub et al. 6 did a scoping review to examine the risk factors contributing to diabetic foot complications in patients with type 2 diabetes mellitus (DM) and chronic kidney disease (CKD).Key risk factors identified were anemia, peripheral arterial disease (PAD), chronic infection, gangrene, poor glycemic control, systemic inflammation, and immune dysfunction, again highlighting the role of multidisciplinary management.Despite the ongoing research and multiple advances, obstacles remain.Access to multidisciplinary care is uneven across regions;